1. Home
  2. SCPH vs PFD Comparison

SCPH vs PFD Comparison

Compare SCPH & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • PFD
  • Stock Information
  • Founded
  • SCPH 2013
  • PFD 1990
  • Country
  • SCPH United States
  • PFD United States
  • Employees
  • SCPH N/A
  • PFD N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • PFD Investment Managers
  • Sector
  • SCPH Health Care
  • PFD Finance
  • Exchange
  • SCPH Nasdaq
  • PFD Nasdaq
  • Market Cap
  • SCPH 173.6M
  • PFD 143.2M
  • IPO Year
  • SCPH 2017
  • PFD N/A
  • Fundamental
  • Price
  • SCPH $5.17
  • PFD $11.39
  • Analyst Decision
  • SCPH Strong Buy
  • PFD
  • Analyst Count
  • SCPH 3
  • PFD 0
  • Target Price
  • SCPH $14.00
  • PFD N/A
  • AVG Volume (30 Days)
  • SCPH 307.4K
  • PFD 33.2K
  • Earning Date
  • SCPH 08-13-2025
  • PFD 01-01-0001
  • Dividend Yield
  • SCPH N/A
  • PFD 6.30%
  • EPS Growth
  • SCPH N/A
  • PFD N/A
  • EPS
  • SCPH N/A
  • PFD N/A
  • Revenue
  • SCPH $41,982,000.00
  • PFD N/A
  • Revenue This Year
  • SCPH $108.95
  • PFD N/A
  • Revenue Next Year
  • SCPH $73.83
  • PFD N/A
  • P/E Ratio
  • SCPH N/A
  • PFD N/A
  • Revenue Growth
  • SCPH 138.10
  • PFD N/A
  • 52 Week Low
  • SCPH $1.94
  • PFD $8.53
  • 52 Week High
  • SCPH $6.28
  • PFD $11.18
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 59.99
  • PFD 55.73
  • Support Level
  • SCPH $5.37
  • PFD $11.25
  • Resistance Level
  • SCPH $5.70
  • PFD $11.38
  • Average True Range (ATR)
  • SCPH 0.32
  • PFD 0.09
  • MACD
  • SCPH -0.02
  • PFD -0.01
  • Stochastic Oscillator
  • SCPH 42.19
  • PFD 75.86

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated

Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: